-
Je něco špatně v tomto záznamu ?
Understanding PACS2 syndrome's pathomechanism by studying E209K and E211K mutations
A. Zbikowski, T. Kowalczyk, P. Kasparek, J. Prohazka, R. Sedlacek, M. Ciborowski, D. Cysewski, K. Łukasiewicz
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
Grantová podpora
B.SUB.24.525
Uniwersytet Medyczny w Bialymstoku
Visegrad Fellowship #62410114
International Visegrad Fund
- MeSH
- indukované pluripotentní kmenové buňky metabolismus MeSH
- lidé MeSH
- missense mutace * MeSH
- mutace MeSH
- vezikulární transportní proteiny * genetika metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Phosphofurin acidic cluster sorting protein 2 (PACS2) plays a vital role in maintaining cellular homeostasis by regulating protein trafficking between cellular membranes. This function impacts crucial processes like apoptosis, mitochondria-endoplasmic reticulum interaction, and subsequently Ca2+ flux, lipid biosynthesis, and autophagy. Missense mutations, particularly E209K and E211K, are linked to developmental and epileptic encephalopathy-66 (DEE66), known as PACS2 syndrome. Individuals with this syndrome exhibit neurodevelopmental delay, seizures, facial dysmorphism, hypotonia, and delayed motor skills.Understanding the impact of these missense mutations on molecular processes is crucial. Studies suggest that E209K mutation decreases phosphorylation, increases the survival time of protein, and modifies protein-protein interaction, consequently leading to disruption of calcium flux and lower resistance to apoptosis induction. Unfortunately, to date, only a limited number of research groups have investigated the effects of mutations in the PACS2 gene. Current research on PACS2 syndrome is hampered by the lack of suitable models. While in vitro models using transfected cell lines offer insights, they cannot fully capture the disease's complexity.To address this, utilizing cells from individuals with PACS2 syndrome, specifically induced pluripotent stem cells (iPSCs), holds promise for understanding phenotypic diversity and developing personalized therapies. However, iPSC models may not fully capture tissue-specific effects of the E209K/E211K mutation. In vivo studies using animal models, particularly mice, could overcome these limitations.This review summarizes current knowledge about PACS2 structure and functions, explores the cellular consequences of E209K and E211K mutations, and highlights the potential of iPSC and mouse models in advancing our understanding of PACS2 syndrome.
Clinical Research Centre Medical University of Bialystok Bialystok Poland
Department of Psychiatry Medical University of Bialystok Bialystok Poland
Experimental Medicine Centre Medical University of Bialystok Bialystok Poland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015577
- 003
- CZ-PrNML
- 005
- 20250731091106.0
- 007
- ta
- 008
- 250708s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00335-024-10098-5 $2 doi
- 035 __
- $a (PubMed)39738582
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Zbikowski, Arkadiusz $u Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland
- 245 10
- $a Understanding PACS2 syndrome's pathomechanism by studying E209K and E211K mutations / $c A. Zbikowski, T. Kowalczyk, P. Kasparek, J. Prohazka, R. Sedlacek, M. Ciborowski, D. Cysewski, K. Łukasiewicz
- 520 9_
- $a Phosphofurin acidic cluster sorting protein 2 (PACS2) plays a vital role in maintaining cellular homeostasis by regulating protein trafficking between cellular membranes. This function impacts crucial processes like apoptosis, mitochondria-endoplasmic reticulum interaction, and subsequently Ca2+ flux, lipid biosynthesis, and autophagy. Missense mutations, particularly E209K and E211K, are linked to developmental and epileptic encephalopathy-66 (DEE66), known as PACS2 syndrome. Individuals with this syndrome exhibit neurodevelopmental delay, seizures, facial dysmorphism, hypotonia, and delayed motor skills.Understanding the impact of these missense mutations on molecular processes is crucial. Studies suggest that E209K mutation decreases phosphorylation, increases the survival time of protein, and modifies protein-protein interaction, consequently leading to disruption of calcium flux and lower resistance to apoptosis induction. Unfortunately, to date, only a limited number of research groups have investigated the effects of mutations in the PACS2 gene. Current research on PACS2 syndrome is hampered by the lack of suitable models. While in vitro models using transfected cell lines offer insights, they cannot fully capture the disease's complexity.To address this, utilizing cells from individuals with PACS2 syndrome, specifically induced pluripotent stem cells (iPSCs), holds promise for understanding phenotypic diversity and developing personalized therapies. However, iPSC models may not fully capture tissue-specific effects of the E209K/E211K mutation. In vivo studies using animal models, particularly mice, could overcome these limitations.This review summarizes current knowledge about PACS2 structure and functions, explores the cellular consequences of E209K and E211K mutations, and highlights the potential of iPSC and mouse models in advancing our understanding of PACS2 syndrome.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a vezikulární transportní proteiny $x genetika $x metabolismus $7 D033921
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a missense mutace $7 D020125
- 650 _2
- $a indukované pluripotentní kmenové buňky $x metabolismus $7 D057026
- 650 _2
- $a mutace $7 D009154
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kowalczyk, Tomasz $u Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland
- 700 1_
- $a Kasparek, Petr $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Prohazka, Jan $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Sedlacek, Radislav $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Ciborowski, Michał $u Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland
- 700 1_
- $a Cysewski, Dominik $u Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland. dominik.cysewski@umb.edu.pl
- 700 1_
- $a Łukasiewicz, Kacper $u Experimental Medicine Centre, Medical University of Bialystok, Bialystok, Poland. kacper.lukasiewicz@umb.edu.pl $u Department of Psychiatry, Medical University of Bialystok, Bialystok, Poland. kacper.lukasiewicz@umb.edu.pl
- 773 0_
- $w MED00003189 $t Mammalian genome $x 1432-1777 $g Roč. 36, č. 2 (2025), s. 363-371
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39738582 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091101 $b ABA008
- 999 __
- $a ok $b bmc $g 2366433 $s 1252702
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 36 $c 2 $d 363-371 $e 20241230 $i 1432-1777 $m Mammalian genome $n Mamm Genome $x MED00003189
- GRA __
- $a B.SUB.24.525 $p Uniwersytet Medyczny w Bialymstoku
- GRA __
- $a Visegrad Fellowship #62410114 $p International Visegrad Fund
- LZP __
- $a Pubmed-20250708